Providing Quality HIV Care

The Latest

empty shot

This Week in HIV Research: The Complexities of Alcohol and Substance Use

April 15, 2021: Alcohol and neurocognitive impairment; using hair analysis to measure substance use; integrase inhibitors' impact on verbal learning; hepatocellular carcinoma trends among PLWH.

By Barbara Jungwirth and Myles Helfand
Sundararajan Team and TBA

Traditional Healers Offer a Culturally Competent Approach to HIV Testing Gaps

In sub-Saharan Africa, herbalists and spiritual healers are working closely with researchers to help reduce HIV transmission in rural communities.

By Terri Wilder, M.S.W.
David Alain Wohl recaps CROI 2021 research during a video interview
Conference Coverage

CROI 2021 Highlights: New HIV Research With Clinical Impact

Here's a walkthrough of some of the most compelling stories coming out of the year's biggest HIV science meeting to date.

By Myles Helfand
thumbnail CITY Jeremy Tjhung-25033

Most Cancer Drug Trials Still Exclude People With HIV. That’s Both Unfounded and Dangerous.

Helping my longtime friend Jeremy find such trials alerted me to this ongoing problem—which will only be reversed if patients, doctors, and trial reviewers keep pushing back on Pharma.

By Tim Murphy
clinical trial

Clinical Trial Data Needs to Reflect the Demographics of HIV, Say Activists

A recent analysis conducted by the AIDS Treatment Activists Coalition revealed that, among HIV drug trial participants, data specific to race and sex were dramatically underreported.

By Terri Wilder, M.S.W.

Long-Acting ART Is Here. How Do We Make It Work for Our Patients?

Injectable HIV interventions are a game-changing new option for people dealing with pill fatigue, but there are implementation challenges for clinicians to consider.

By Larry Buhl
photo of David Alain Wohl, M.D., as he recaps research from CROI 2021
Conference Coverage

Sleep and Diet: Don’t Underestimate Their Importance for People Living With HIV

David Alain Wohl, M.D., on new findings from CROI 2021 that help us better understand the connections between sleep, diet, and quality of life among people living with HIV.

By David Alain Wohl, M.D.
Hippocratic oath

This Week in HIV Research: U=U and the Hippocratic Oath

April 1, 2021: The ethics of teaching U=U; the role of primary care in HIV service acceptance; STI testing rates in transgender women; the potential in anal self-sampling.

By Barbara Jungwirth and Myles Helfand
The main entrance to Grady Health System in downtown Atlanta, Georgia

How Can Clinics Become Safer Places for Transgender Women to Access PrEP?

Researchers recommend PrEP programs be linked to a gender-affirming care clinic, to build trust and retain patients in care.

By Mathew Rodriguez
street entrance to the building containing the HIV clinic at Zuckerberg San Francisco General Hospital and Trauma Center

This San Francisco Clinic Is Rethinking Care for People Living With HIV Experiencing Homelessness

The results: 79% of enrolled participants restarted their antiretroviral therapy within a week of enrolling, and 55% were virally suppressed after six months.

By Larry Buhl

Meet the Experts

Paul E. Sax, M.D. Img
Paul E. Sax, M.D.

Dr. Sax is director of the HIV Program and Division of Infectious Diseases at Brigham and Women's Hospital (BWH) in Boston.

David Alain Wohl, M.D. Img
David Alain Wohl, M.D.

David Alain Wohl, M.D., is a professor at the University of North Carolina, site leader of the UNC AIDS Clinical Trials Unit at Chapel Hill, director of the North Carolina AETC, and co-director of HIV services for the NC state prison system.